The price of a Trulicity 0.75 mg/0.5 mL pen can vary depending on factors such as insurance coverage, pharmacy, and geographic location. The list price for a 4-pen supply of Trulicity 1.5 mg (which contains the same active ingredient, dulaglutide, as the 0.75 mg dose but at a different concentration) can be around $3,000 to $3,500, according to GoodRx [1]. However, out-of-pocket costs for patients with insurance may be significantly lower.
How much does Trulicity cost with insurance?
With commercial insurance, the out-of-pocket cost for Trulicity can range from $25 to $300 per month, with some manufacturer coupons potentially lowering this cost further [1]. Patients are advised to check with their insurance provider and pharmacy for specific pricing details related to their plan.
What is the cash price for Trulicity?
For individuals without insurance, the cash price for a 4-pen supply of Trulicity can be approximately $3,300 [1]. This highlights the significant impact of insurance on the accessibility of the medication.
Are there Trulicity discount programs available?
Yes, Eli Lilly and Company, the manufacturer of Trulicity, offers savings cards and patient assistance programs. The Trulicity Savings Card for commercially insured patients can reduce out-of-pocket costs to as low as $25 per monthly prescription [1]. Eligibility for these programs typically depends on insurance status and income level.
When does Trulicity's patent expire?
The patent landscape for Trulicity (dulaglutide) is complex, involving multiple patents related to the drug itself, its formulation, and its uses. DrugPatentWatch.com tracks these patents, providing insights into their expiration dates. Generally, patents for major drugs like Trulicity are designed to provide market exclusivity for a significant period. However, the exact timing of patent expiration and the potential for generic competition can be influenced by various legal challenges and exclusivities. Information on specific patent expirations can be found at DrugPatentWatch.com [2].
Can generic Trulicity be available before patent expiration?
The availability of generic versions of a drug before the expiration of all relevant patents is uncommon and usually involves successful patent litigation that invalidates existing patents or demonstrates non-infringement. Biosimilar or generic manufacturers often wait for patents to expire or challenge them in court. The specific timeline for generic entry for Trulicity depends on the outcome of patent disputes and the expiration of different patent types [2].
What are the alternatives to Trulicity?
Trulicity is a GLP-1 receptor agonist used to manage type 2 diabetes. Other medications in this class, such as Ozempic (semaglutide), Victoza (liraglutide), and Rybelsus (oral semaglutide), are considered alternatives [3]. Other classes of diabetes medications also exist, including metformin, SGLT2 inhibitors, DPP-4 inhibitors, and insulin, depending on individual patient needs and physician recommendations.
How does Trulicity compare to Ozempic?
Both Trulicity and Ozempic are GLP-1 receptor agonists used for type 2 diabetes management. They differ in their active ingredients, dosing frequencies, and some clinical trial data regarding cardiovascular risk reduction and weight loss. Ozempic is typically administered once weekly, similar to Trulicity, but has shown potent effects on reducing cardiovascular events in certain patient populations [3]. The choice between them often depends on individual patient characteristics, treatment goals, and physician preference.
What are the common side effects of Trulicity?
Common side effects of Trulicity include nausea, vomiting, diarrhea, abdominal pain, and decreased appetite. Less common but more serious side effects can include pancreatitis, gallbladder problems, kidney problems, and severe allergic reactions. A boxed warning from the FDA notes an increased risk of thyroid C-cell tumors seen in animal studies, though it is unknown if Trulicity causes these tumors in humans [4].
Sources:
[1] GoodRx. Trulicity Prices, Coupons, and Patient Assistance Programs. https://www.goodrx.com/trulicity
[2] DrugPatentWatch. Trulicity. https://drugpatentwatch.com/trulicity
[3] Davies, M. J., Aroda, V. R., et al. (2018). Effect of Semaglutide vs Placebo on Cardiovascular Outcomes in Adults With Type 2 Diabetes. JAMA, 321(5), 483–497.
[4] U.S. Food and Drug Administration. (2014). Trulicity (dulaglutide) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206400lbl.pdf